BioNTech SE (FRA:22UA)
82.00
-1.00 (-1.20%)
At close: Dec 5, 2025
BioNTech SE Employees
BioNTech SE had 6,772 employees as of December 31, 2024. The number of employees increased by 639 or 10.42% compared to the previous year.
Employees
6,772
Change (1Y)
639
Growth (1Y)
10.42%
Revenue / Employee
€465,520
Profits / Employee
€84,406
Market Cap
19.89B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Merck KGaA | 59,020 |
| Siemens Healthineers AG | 73,840 |
| Bayer Aktiengesellschaft | 91,864 |
| Fresenius SE & Co. KGaA | 176,486 |
| Sartorius Aktiengesellschaft | 13,528 |
| Fresenius Medical Care AG | 111,513 |
| Carl Zeiss Meditec AG | 5,730 |
| Fielmann Group AG | 24,363 |
BioNTech SE News
- 2 days ago - BioNTech Secures Majority Of CureVac Shares As Exchange Offer Advances - Nasdaq
- 2 days ago - BioNTech (BNTX) Advances with CureVac Acquisition - GuruFocus
- 2 days ago - BioNTech Achieves Minimum Condition in CureVac Exchange Offer - GlobeNewsWire
- 4 days ago - FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks - Investopedia
- 4 days ago - Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men - Market Watch
- 4 days ago - Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths - Investor's Business Daily
- 8 days ago - BioNTech (BNTX) Q3 2025 Earnings Call Transcript - The Motley Fool
- 9 days ago - BioNTech (BNTX) Moves Forward with CureVac Acquisition - GuruFocus